Article de revue
Immunogenicity, safety, and tolerability of a hexavalent vaccine in infants
The safety and immunogenicity of DTaP5-IPV-Hib-HepB are comparable with the analogous licensed component vaccines. Decreased FHA GMCs and increased injection-site reactions and fever are unlikely to be clinically significant. DTaP5-IPV-Hib-HepB provides a new combination vaccine option aligned with the recommended US infant immunization schedule.
Auteurs
Langues
- Anglais
Année de publication
2015
Journal
Pediatrics
Volume
2
Type
Article de revue
Catégories
- Vaccins et dispositifs d'administration
Maladies
- Diphtérie
- Hépatite B
- HIB
- Coqueluche
- Polio
- Tétanos
